Mode
Text Size
Log in / Sign up

Clinical Trial Search

Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.

Phase
Intervention
Population
Results posted

65,437 trials

Phase 3 N=36 A Study to Learn How Safe the Study Treatment BAY94-9027 is and How it Affects the Body in Previously Treated Children Aged 7 to Less Than 12 Years With Severe Hemophilia A, a Genetic Bleeding Disorder That is Caused by the Lack of a Protein Called Clotting Factor 8 (FVIII) in the Blood

Treatment of Bleeding · Prophylaxis of Bleeding · Hemophilia A
Primary: Adverse Events of Special Interest (AESI) Hypersensitivity and Loss of Efficacy Associated With the First 4 Exposure Days (EDs) Leading to Discontinuation — 1 Participants
Bayer Results Jul 2025 2.9% serious AE View details

N/A N=52 BIO|CONCEPT.Amvia Study

Bradycardia · Heart Failure
Primary: Serious Adverse Device Effect (SADE)-Free Rate After 12 Months — 52 Participants
Biotronik Australia Pty Ltd. Results Jul 2025 57.7% serious AE View details